Literature DB >> 17444782

Percutaneous treatment of calculi in reconstructed bladder.

Edgar Paez1, Emma Reay, L N S Murthy, Robert S Pickard, David J Thomas.   

Abstract

PURPOSE: To report our results with percutaneous removal of calculi from reconstructed bladders. PATIENTS AND METHODS: Twelve patients with reconstructed bladders who underwent endoscopic cystolithotomy were identified from our departmental database, and retrospective review of case notes and imaging was performed.
RESULTS: Access was gained via an ultrasound-guided new tract in 9 patients (75%). An old suprapubic tract site was used in two patients, and the Mitrofanoff stoma was the route of access in one patient. The procedure was successful, with stone clearance achieved in all 12 cases. No major complications were observed. At a median follow up of 24 months, stone recurrence was observed in 5 patients (42%), 4 of whom underwent repeat procedures. Follow-up showed no change in continence in the patient with a Mitroffanoff stoma.
CONCLUSION: Percutaneous cystolithotomy is a safe and effective minimally invasive option for removal of stones in a reconstructed bladder. We recommend endoscopic removal as the treatment of choice in these patients.

Entities:  

Mesh:

Year:  2007        PMID: 17444782     DOI: 10.1089/end.2006.0251

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  2 in total

1.  Retrograde-Assisted Percutaneous Cystolitholapaxy Versus Transurethral Cystolithotripsy With Holmium-YAG Laser: A Retrospective Study.

Authors:  Shahrokh Sakhaei; Morteza Fallah-Karkan; Mohammadreza Razzaghi; Babak Kazemzadeh Azad; Fereshteh Aliakbari
Journal:  J Lasers Med Sci       Date:  2019-12-01

2.  Percutaneous treatment of bladder stones in children: 10 years experience, is blind access safe?

Authors:  Hassan Ahmadnia; Ali Kamalati; Mehdi Younesi; Mohammad Mehdi Imani; Mahmoodreza Moradi; Mohammad Esmaeili
Journal:  Pediatr Surg Int       Date:  2013-05-07       Impact factor: 1.827

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.